High-throughput quantitative screening of ...
Type de document :
Pré-publication ou Document de travail
Titre :
High-throughput quantitative screening of glucose-stimulated insulin secretion and insulin content using automated MALDI-TOF mass spectrometry
Auteur(s) :
Delannoy, Clément Philippe [Auteur]
Heuson, Egon [Auteur]
Herledan, Adrien [Auteur]
Oger, Frederik [Auteur]
Thiroux, Bryan [Auteur]
Chevalier, Mickaël [Auteur]
Gromada, Xavier [Auteur]
Rolland, Laure [Auteur]
Froguel, Philippe [Auteur]
Deprez, Benoit [Auteur]
Paul, Sebastien [Auteur]
Annicotte, Jean-Sébastien [Auteur correspondant]
Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167 [RID-AGE]
Metabolic functional (epi)genomics and molecular mechanisms involved in type 2 diabetes and related diseases - UMR 8199 - UMR 1283 [EGENODIA (GI3M)]
Heuson, Egon [Auteur]
Herledan, Adrien [Auteur]
Oger, Frederik [Auteur]
Thiroux, Bryan [Auteur]
Chevalier, Mickaël [Auteur]
Gromada, Xavier [Auteur]
Rolland, Laure [Auteur]
Froguel, Philippe [Auteur]
Deprez, Benoit [Auteur]
Paul, Sebastien [Auteur]
Annicotte, Jean-Sébastien [Auteur correspondant]
Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167 [RID-AGE]
Metabolic functional (epi)genomics and molecular mechanisms involved in type 2 diabetes and related diseases - UMR 8199 - UMR 1283 [EGENODIA (GI3M)]
Date de publication :
2023-02-15
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
Abstract Type 2 diabetes (T2D) is a metabolic disorder characterized by loss of pancreatic β- cell function, decreased insulin secretion and increased insulin resistance, that affects more than 400 million people worldwide. ...
Lire la suite >Abstract Type 2 diabetes (T2D) is a metabolic disorder characterized by loss of pancreatic β- cell function, decreased insulin secretion and increased insulin resistance, that affects more than 400 million people worldwide. Although several treatments are proposed to patients suffering from T2D, long-term control of glycemia remains a challenge. Therefore, identifying new potential drugs and targets that positively affect β-cell function and insulin secretion remains crucial. Here, we developed an automated approach to allow the identification of new compounds or genes potentially involved in β-cell function in a 384-well plate format, using the murine β-cell model Min6. Using MALDI-TOF mass spectrometry, we have implemented a high-throughput screening (HTS) strategy based on the automation of a cellular assay allowing to detect insulin secretion in response to glucose, quantitative detection of insulin, in a miniaturized system. As a proof of concept, we screened siRNA targeting well-know β-cell genes and 1600 chemical compounds and identified several molecules as potential regulators of insulin secretion and/or synthesis, demonstrating that our approach allows HTS of insulin secretion in vitro .Lire moins >
Lire la suite >Abstract Type 2 diabetes (T2D) is a metabolic disorder characterized by loss of pancreatic β- cell function, decreased insulin secretion and increased insulin resistance, that affects more than 400 million people worldwide. Although several treatments are proposed to patients suffering from T2D, long-term control of glycemia remains a challenge. Therefore, identifying new potential drugs and targets that positively affect β-cell function and insulin secretion remains crucial. Here, we developed an automated approach to allow the identification of new compounds or genes potentially involved in β-cell function in a 384-well plate format, using the murine β-cell model Min6. Using MALDI-TOF mass spectrometry, we have implemented a high-throughput screening (HTS) strategy based on the automation of a cellular assay allowing to detect insulin secretion in response to glucose, quantitative detection of insulin, in a miniaturized system. As a proof of concept, we screened siRNA targeting well-know β-cell genes and 1600 chemical compounds and identified several molecules as potential regulators of insulin secretion and/or synthesis, demonstrating that our approach allows HTS of insulin secretion in vitro .Lire moins >
Langue :
Anglais
Collections :
Source :
Fichiers
- document
- Accès libre
- Accéder au document
- BIORXIV-2023-528514v1-Annicotte.pdf
- Accès libre
- Accéder au document
- document
- Accès libre
- Accéder au document
- BIORXIV-2023-528514v1-Annicotte.pdf
- Accès libre
- Accéder au document